Home | Welcome to Contract Pharma   
Last Updated Tuesday, September 30 2014
Print

Financial Report: BASi



Published December 28, 2012
BASi

4Q Revenues: $6.5 million (-20%)

4Q Loss: $2.3 million (loss of $668,000 4Q11)

YTD Revenues: $28.2 million (-15%)

YTD Loss: $6.4 million (earnings were $543,000 YTD11)

Comments: Service revenue was down 17% in the quarter to $5.2 million. Product revenue was down 29% to $1.3 million. Restructuring charges were $2.5 million in the quarter and $3.2 million for the year. Revenue decline is attributed to the consolidation of the company's Oregon facility into its West Lafayette facility and the closure of its UK lab.


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On